Multiplex Assays Market worth $10.65 billion by 2031
The report "Multiplex Assays Market by Product & Service (Consumable, Instrument), Type (Protein, Nucleic Acid), Technology (Flow Cytometry), Application [R&D, Diagnostics (Infectious Disease, Cancer)], End User (Hospital, Research Institute)-Global Forecast to 2031" is estimated at USD 7.15 billion in 2026 and is forecasted to reach USD 10.65 billion by 2031, at a CAGR of 8.3% during the period.
Browse 312 market data Tables and 50 Figures spread through 350 Pages and in-depth TOC on "Multiplex Assays Market, by Product & Service (Consumable, Instrument), Type (Protein, Nucleic Acid), Technology (Flow Cytometry), Application [R&D, Diagnostics (Infectious Disease, Cancer)], End User (Hospital, Research Institute)-Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html
The global market for multiplex assays is expected to grow steadily over the coming years for several reasons. These include an increase in the incidence of infectious diseases, cancers, and autoimmune disorders, as well as a growing demand for high-throughput testing and greater emphasis on disease diagnosis. The rise of personalized medicine and companion diagnostics will further expand the multiplex assays market. Additionally, the adoption of advanced technologies such as multiplex PCR, immunoassays, and sequencing techniques, along with the increasing number of diagnostic laboratories and research facilities, will create new opportunities for growth in this sector.
By technology, the flow cytometry segment accounted for the largest market share in 2025.
This market is classified into flow cytometry, fluorescence detection, multiplex real-time PCR, luminescence, next-generation sequencing (NGS), and other techniques. Some of the growth drivers of the flow cytometry segment are its superior sensitivity, multiparametric analysis capability, and high utility in immunology, oncology, and cellular research. In addition, the increasing prevalence of molecular diagnostics, the growing number of diagnostic centers, and technological advancements in automation and analysis are also anticipated to drive demand for multiplex assays.
By application, the clinical diagnostics segment accounted for the largest market share in 2025.
The market is divided into the research & development and clinical diagnostics segments. Some of the key factors driving the growth of the clinical diagnostics segment are the rising demand for fast, accurate multi-target disease identification, the increasing incidence of infectious diseases and cancers, and the growing use of syndromic testing panels in healthcare facilities. Furthermore, the growing importance of early diagnosis, personalized therapy selection, and advancements in diagnostic infrastructure are driving this segment's growth. On the other hand, R&D demand remains robust owing to the rising discovery of biomarkers and drug development worldwide.
By end user, the pharmaceutical & biotech companies segment accounted for the largest market share in 2025.
This market is segmented into pharmaceutical & biotech companies, hospitals & diagnostic laboratories, academic & research institutes, contract research organizations, and other end users. Factors expected to drive growth in the pharmaceutical & biotech companies market include rising test volumes, the need for multiplexed analysis, and the growing adoption of automation in diagnostic procedures. In addition, an increase in the incidence of infections and cancers, along with improvements in healthcare infrastructure, is another driver of demand.
North America dominated the multiplex assay market in 2025.
The multiplex assay market is segmented into five geographical regions: Asia Pacific, Latin America, North America, Europe, and the Middle East & Africa. In 2026, North America held the largest market share in the multiplex assay market. This growth can be attributed to a highly advanced healthcare industry, the presence of well-established biotechnology and diagnostics companies, and the use of innovative technologies. Additionally, North America benefits from a significant number of advanced hospitals, research institutes, and diagnostic centers. An increase in the prevalence of infections and cancer cases is also driving market growth in this region.
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), DiaSorin S.p.A. (Italy), Revvity, Inc. (US), and bioMérieux (France), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Multiplex Assays Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
